TL;DR: Triomics is a Y Combinator Winter 2021 startup AI Agents for Oncology EHRs, currently active with a team of 50.
AI Agents for Oncology EHRs
Last verified:
Triomics is building the AI infrastructure for modern oncology. Across the U.S., cancer care providers rely on highly trained staff to manually review unstructured patient records such as pathology reports, clinical notes, genomic panels, and scanned faxes to support workflows like clinical trial matching, visit preparation, and quality reporting. We replace that manual work with task-driven AI agents embedded directly into clinical workflows, automatically processing medical records at scale and in real time. Our platform is trusted by 4 of the top 10 Best Hospitals for Cancer ranked by U.S. News, as well as several of the largest community oncology practices.
Built by LemStudio
Yes. Triomics was funded by Y Combinator in the Winter 2021 batch. AI Agents for Oncology EHRs
Triomics is building the AI infrastructure for modern oncology. Across the U.S., cancer care providers rely on highly trained staff to manually review unstructured patient records such as pathology reports, clinical notes, genomic panels, and scanned faxes to support workflows like clinical trial matching, visit prepa…
Triomics was part of Y Combinator's Winter 2021 batch.
Triomics has a team of 50 people according to Y Combinator's directory.
Triomics is currently listed as Active with a team of 50 in Y Combinator's directory.
Loading interactive view…